Catalyst Wire Dossier Catalyst Wire Dossier

Lymphdiaral Basistropfen (HDC)

· Pascoe Pharmazeutische Praeparate GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lymphdiaral Basistropfen (HDC), covering 2012-09-06 to 2012-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lymphdiaral Basistropfen (HDC) in the Treatment of Chronic Low-back Pain [Phase 3]

See pricing